Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
- Status
- COMPLETED
- Phase
- NA
A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
- Status
- TERMINATED
- Phase
- PHASE2
A Safety Study in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel
- Status
- COMPLETED
- Phase
- N/A
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel
- Status
- COMPLETED
- Phase
- PHASE2